17 research outputs found
Exchange Rates, Expectations, and Monetary Policy: a NOEM Perspective
Glucocorticoids (GC) have important anti-inflammatory and pro-apoptotic activities. Initially thought to be exclusively produced by the adrenal glands, there is now increasing evidence for extra-adrenal sources of GCs. We have previously shown that the intestinal epithelium produces immunoregulatory GCs and that intestinal steroidogenesis is regulated by the nuclear receptor liver receptor homolog-1 (LRH-1). As LRH-1 has been implicated in the development of colon cancer, we here investigated whether LRH-1 regulates GC synthesis in colorectal tumors and whether tumor-produced GCs suppress T-cell activation. Colorectal cancer cell lines and primary tumors were found to express steroidogenic enzymes and regulatory factors required for the de novo synthesis of cortisol. Both cell lines and primary tumors constitutively produced readily detectable levels of cortisol, as measured by radioimmunoassay, thin-layer chromatography and bioassay. Whereas overexpression of LRH-1 significantly increased the expression of steroidogenic enzymes and the synthesis of cortisol, downregulation or inhibition of LRH-1 effectively suppressed these processes, indicating an important role of LRH-1 in colorectal tumor GC synthesis. An immunoregulatory role of tumor-derived GCs could be further confirmed by demonstrating a suppression of T-cell activation. This study describes for the first time cortisol synthesis in a non-endocrine tumor in humans, and suggests that the synthesis of bioactive GCs in colon cancer cells may account as a novel mechanism of tumor immune escape
CAR regulates epithelial cell junction stability through control of E-cadherin trafficking
The GRIP1:IRF3 interaction as a target for glucocorticoid receptor-mediated immunosuppression
Glucocorticoids dramatically inhibit cytokine and chemokine production. They act through the glucocorticoid receptor (GR), a ligand-dependent transcription factor that binds to and represses activities of other DNA-bound regulators, activator protein 1 and nuclear factor κB, utilizing a p160 GRIP1 as a corepressor. A yeast two-hybrid screen with the GRIP1 corepression domain (RD) yielded interferon (IFN) regulatory factor (IRF)3—a downstream effector of Toll-like receptors (TLR) 3/4 and an essential activator of several IFN and chemokine genes. We defined the GRIP1:IRF3 interface and showed that endogenous GRIP1 and IRF3 interact in mammalian cells. Interestingly, GR and IRF3 competed for GRIP1 binding; GR activation or GRIP1 knockdown in macrophages blocked whereas GRIP1 overexpression rescued IRF3-dependent gene expression. GR interference persisted in MyD88- and IFNA receptor-deficient mice, suggesting a specific disruption of TLR3–IRF3 pathway, not of autocrine IFN signaling. Finally, IRF3-stimulated response elements were necessary and sufficient for TLR3-dependent induction and glucocorticoid inhibition. Thus, GRIP1 plays a cofactor role in innate immunity. Competition with GR for GRIP1 antagonizes IRF3-mediated transcription, identifying the GRIP1:IRF3 interaction as a novel target for glucocorticoid immunosuppression
Extra-adrenal glucocorticoid synthesis in the intestinal epithelium: more than a drop in the ocean?
Glucocorticoids (GC) are lipophilic hormones commonly used as therapeutics in acute and chronic inflammatory disorders such as inflammatory bowel disease due to their attributed anti-inflammatory and immunosuppressive actions. Although the adrenal glands are the major source of endogenous GC, there is increasing evidence for the production of extra-adrenal GC in the brain, thymus, skin, vasculature, and the intestine. However, the physiological relevance of extra-adrenal-produced GC remains still ambiguous. Therefore, this review attracts attention to discuss possible biological benefits of extra-adrenal-synthesized GC, especially focusing on the impact of locally synthesized GC in the regulation of intestinal immune responses
Extra-adrenal glucocorticoid synthesis in the intestinal epithelium: more than a drop in the ocean?
Genetics and genomics of stomatal traits for improvement of abiotic stress tolerance in cereals
In traditional breeding programmes for improving abiotic stress tolerance of cereals , direct selection for grain yield is slow and costly, requiring many years and sites of field trials. Grain yield largely depends on the flag leaf characteristics and functions and is correlated to the ability of the plant to regulate its water content and to synthesize, store and relocate carbohydrates from leaves to grains. Despite the recognition of the importance of the flag leaf in cereals , little is known about genetic control of its cellular structure and development under stress. The leaf stomata cells regulate water loss by transpiration and photosynthetic CO2 uptake in plants. In order to maintain a high photosynthetic rate for higher yield under drought and salinity conditions, it is critical to explore the mechanisms of control of stomata. A major crucial challenge in breeding for abiotic stress tolerance is the knowledge about the physiological and genetic mechanisms that regulate stomatal morphology and development connected to grain yield. Quantitative trait loci (QTL) mapping has been used to identify the genes that are subject to natural variation of stomatal traits in wheat, barley and rice. Over the last decade, several studies have demonstrated the importance of stomatal density and size and their positive association with physiological processes in grain yield. Further, considerable genetic variation exists for stomatal and epidermal cell traits that could be exploited for marker-assisted breeding and used for creation of new effective traits in cereals
